{"entity":{"type":"insider","cik":"0001750050","url":"/insider/0001750050","json_url":"/insider/0001750050.json","name":"Sukhatme Mayukh","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":8,"first":"2024-12-20","last":"2026-08-21","span_basis":"filed_date"},"name_variants":[{"name":"Sukhatme Mayukh","source":"filing","n_filings":8,"first_seen":"2024-12-20","last_seen":"2026-08-21"}],"transactions":[{"id":9300225,"accession":"0001140361-26-034066","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-26-034066","line_url":"/filing/0001140361-26-034066#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (President & CIO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CIO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":144756.0,"shares_display":"144,756","price_per_share":36.48,"price_display":"36.48","price_state":"stated","total_value":5280698.88,"total_display":"5,280,698.88","total_whole":"5,280,699","shares_owned_after":18630739.0,"shares_owned_after_display":"18,630,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-21","scope":"insider"},{"id":9300226,"accession":"0001140361-26-034066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-26-034066","line_url":"/filing/0001140361-26-034066#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (President & CIO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CIO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17519.0,"shares_display":"17,519","price_per_share":37.3,"price_display":"37.30","price_state":"stated","total_value":653458.7,"total_display":"653,458.70","total_whole":"653,459","shares_owned_after":18630739.0,"shares_owned_after_display":"18,630,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"insider"},{"id":9300227,"accession":"0001140361-26-034066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-26-034066","line_url":"/filing/0001140361-26-034066#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (President & CIO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CIO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":172899.0,"shares_display":"172,899","price_per_share":37.17,"price_display":"37.17","price_state":"stated","total_value":6426655.83,"total_display":"6,426,655.83","total_whole":"6,426,656","shares_owned_after":18630739.0,"shares_owned_after_display":"18,630,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-21","scope":"insider"},{"id":9233752,"accession":"0001140361-26-033637","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-26-033637","line_url":"/filing/0001140361-26-033637","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (President & CIO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CIO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136942.0,"shares_display":"136,942","price_per_share":36.72701121642739,"price_display":"36.73","price_state":"stated","total_value":5029470.37,"total_display":"5,029,470.37","total_whole":"5,029,470","shares_owned_after":18630739.0,"shares_owned_after_display":"18,630,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-18","scope":"insider","n_lines":2},{"id":9233751,"accession":"0001140361-26-033637","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-26-033637","line_url":"/filing/0001140361-26-033637#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (President & CIO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CIO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":284707.0,"shares_display":"284,707","price_per_share":36.25,"price_display":"36.25","price_state":"stated","total_value":10320628.75,"total_display":"10,320,628.75","total_whole":"10,320,629","shares_owned_after":18630739.0,"shares_owned_after_display":"18,630,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-18","scope":"insider"},{"id":9233750,"accession":"0001140361-26-033637","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-26-033637","line_url":"/filing/0001140361-26-033637#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (President & CIO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CIO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":243177.0,"shares_display":"243,177","price_per_share":36.23,"price_display":"36.23","price_state":"stated","total_value":8810302.71,"total_display":"8,810,302.71","total_whole":"8,810,303","shares_owned_after":18630739.0,"shares_owned_after_display":"18,630,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-14","filed_date":"2026-08-18","scope":"insider"},{"id":5948608,"accession":"0001635088-26-000073","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001635088-26-000073","line_url":"/filing/0001635088-26-000073#line-4","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (President & CIO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CIO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":34.08,"price_display":"34.08","price_state":"stated","total_value":17040000.0,"total_display":"17,040,000.00","total_whole":"17,040,000","shares_owned_after":18677617.0,"shares_owned_after_display":"18,677,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-29","scope":"insider"},{"id":5948604,"accession":"0001635088-26-000073","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001635088-26-000073","line_url":"/filing/0001635088-26-000073#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (President & CIO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CIO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":34.13,"price_display":"34.13","price_state":"stated","total_value":17065000.0,"total_display":"17,065,000.00","total_whole":"17,065,000","shares_owned_after":18677617.0,"shares_owned_after_display":"18,677,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-25","filed_date":"2026-06-29","scope":"insider"},{"id":6157414,"accession":"0001635088-26-000015","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001635088-26-000015","line_url":"/filing/0001635088-26-000015#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (President & CIO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CIO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":339441.0,"shares_display":"339,441","price_per_share":26.47,"price_display":"26.47","price_state":"stated","total_value":8985003.27,"total_display":"8,985,003.27","total_whole":"8,985,003","shares_owned_after":19148664.0,"shares_owned_after_display":"19,148,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-09","filed_date":"2026-02-11","scope":"insider"},{"id":4031386,"accession":"0001140361-25-047122","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-25-047122","line_url":"/filing/0001140361-25-047122#line-6","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (President & CIO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CIO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1018995.0,"shares_display":"1,018,995","price_per_share":21.71,"price_display":"21.71","price_state":"stated","total_value":22122381.45,"total_display":"22,122,381.45","total_whole":"22,122,381","shares_owned_after":20267429.0,"shares_owned_after_display":"20,267,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-31","filed_date":"2025-12-31","scope":"insider"},{"id":4031383,"accession":"0001140361-25-047122","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-047122","line_url":"/filing/0001140361-25-047122#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (President & CIO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CIO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":311873.0,"shares_display":"311,873","price_per_share":21.74,"price_display":"21.74","price_state":"stated","total_value":6780119.02,"total_display":"6,780,119.02","total_whole":"6,780,119","shares_owned_after":19273032.0,"shares_owned_after_display":"19,273,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-29","filed_date":"2025-12-31","scope":"insider"},{"id":4134723,"accession":"0001140361-25-046247","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-25-046247","line_url":"/filing/0001140361-25-046247#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (President & CIO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CIO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26831.0,"shares_display":"26,831","price_per_share":23.09,"price_display":"23.09","price_state":"stated","total_value":619527.79,"total_display":"619,527.79","total_whole":"619,528","shares_owned_after":18869229.0,"shares_owned_after_display":"18,869,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-17","filed_date":"2025-12-19","scope":"insider"},{"id":2150652,"accession":"0001140361-24-050461","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-24-050461","line_url":"/filing/0001140361-24-050461#line-6","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (Pres&Chief Investment Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres&Chief Investment Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":689495.0,"shares_display":"689,495","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":8280834.95,"total_display":"8,280,834.95","total_whole":"8,280,835","shares_owned_after":18836547.0,"shares_owned_after_display":"18,836,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-26","filed_date":"2024-12-26","scope":"insider"},{"id":2150649,"accession":"0001140361-24-050461","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-24-050461","line_url":"/filing/0001140361-24-050461#line-4","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (Pres&Chief Investment Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres&Chief Investment Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":185946.0,"shares_display":"185,946","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":2231352.0,"total_display":"2,231,352.00","total_whole":"2,231,352","shares_owned_after":18836547.0,"shares_owned_after_display":"18,836,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-24","filed_date":"2024-12-26","scope":"insider"},{"id":2150642,"accession":"0001140361-24-050461","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-24-050461","line_url":"/filing/0001140361-24-050461#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (Pres&Chief Investment Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres&Chief Investment Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10796.0,"shares_display":"10,796","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":129552.0,"total_display":"129,552.00","total_whole":"129,552","shares_owned_after":18836547.0,"shares_owned_after_display":"18,836,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-23","filed_date":"2024-12-26","scope":"insider"},{"id":2937539,"accession":"0001140361-24-050141","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-24-050141","line_url":"/filing/0001140361-24-050141#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Roivant Sciences Ltd.","issuer_ticker":"ROIV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001750050","owner_name":"Sukhatme Mayukh","owner_display_name":"Sukhatme Mayukh","owner_url":"/insider/0001750050","role":"Director, Officer (Pres&Chief Investment Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres&Chief Investment Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":412584.0,"shares_display":"412,584","price_per_share":12.05,"price_display":"12.05","price_state":"stated","total_value":4971637.2,"total_display":"4,971,637.20","total_whole":"4,971,637","shares_owned_after":18836547.0,"shares_owned_after_display":"18,836,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-18","filed_date":"2024-12-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001635088","name":"Roivant Sciences Ltd.","url":"/issuer/0001635088","role":"Director, Officer (President & CIO)","n_filings":8,"first_seen":"2024-12-20","last_seen":"2026-08-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001750050","retrieved_at":"2026-08-25T15:54:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}